Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain

Drug and Alcohol Dependence

Volumn 132, Issue 1-2, 2013, Pages 335-341

  Martel, M O ^a   Wasan, A D ^a   Jamison, R N ^a   Edwards, R R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anxiety; Catastrophizing; Chronic pain; Depression; Prescription opioid misuse

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; BRIEF PAIN INVENTORY; CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MISUSE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYALGIA; PAIN ANXIETY SYMPTOMS SCALE; PAIN ASSESSMENT; PAIN CATASTROPHIZING SCALE; PATIENT ATTITUDE; PRESCRIPTION; PRESCRIPTION DRUG USE QUESTIONNAIRE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SCREENER AND OPIOID ASSESSMENT FOR PATIENTS WITH PAIN REVISED QUESTIONNAIRE; SELF REPORT; SEX DIFFERENCE; STRUCTURED QUESTIONNAIRE;

ANXIETY; CATASTROPHIZING; CHRONIC PAIN; DEPRESSION; PRESCRIPTION OPIOID MISUSE;

ADULT; ANALGESICS, OPIOID; ANXIETY; CATASTROPHIZATION; CHRONIC PAIN; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PAIN MEASUREMENT; PRESCRIPTION DRUG MISUSE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK;

EID: 84881660320     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.02.034     Document Type: Article

References (95)

1. Adams L.L., Gatchel R.J., Robinson R.C. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J. Pain Symptom Manage. 2004, 27:440-459.
2. Akbik H., Butler S.F., Budman S.H., Fernandez K., Katz N.P., Jamison R.N. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J. Pain Symptom Manage. 2006, 32:287-293.
3. Arendt-Nielsen L., Yarnitsky D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J. Pain 2009, 10:556-572.
4. Ball S.A., Carroll K.M., Rounsaville B.J. Sensation seeking, substance abuse, and psychopathology in treatment-seeking and community cocaine abusers. J. Consult. Clin. Psychol. 1994, 62:1053-1057.
5. Ballantyne J.C., LaForge K.S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007, 129:235-255.
6. Ballantyne J.C. Opioid controls: regulate to educate. Pain Med. 2010, 11:480-481.
7. Banta-Green C.J., Merrill J.O., Doyle S.R., Boudreau D.M., Calsyn D.A. Opioid use behaviors, mental health and pain-development of a typology of chronic pain patients. Drug Alcohol Depend. 2009, 104:34-42.
8. Banta-Green C.J., Merrill J.O., Doyle S.R., Boudreau D.M., Calsyn D.A. Measurement of opioid problems among chronic pain patients in a general medical population. Drug Alcohol Depend. 2009, 104:43-49.
9. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51:1173-1182.
10. Beck A., Steer R., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
11. Becker W.C., Sullivan L.E., Tetrault J.M., Desai R.A., Fiellin D.A. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008, 94:38-47.
12. Braden J.B., Sullivan M.D., Ray G.T., Saunders K., Merrill J., Silverberg M.J., Rutter C.M., Weisner C., Banta-Green C., Campbell C., Von Korff M. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen. Hosp. Psychiatry 2009, 6:564-570.
13. Bruehl S., Burns J.W., Chung O.Y., Chont M. Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms. Neurosci. Biobehav. Rev. 2009, 33:475-491.
14. Butler S.F., Budman S.H., Fernandez K., Jamison R.N. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004, 112:65-75.
15. Butler S.F., Fernandez K., Benoit C., Budman S.H., Jamison R.N. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J. Pain 2008, 9:360-372.
16. Butler S.F., Budman S.H., Fernandez K.C., Fanciullo G.J., Jamison R.N. Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R). J. Addict. Med. 2009, 3:66-73.
17. Catz S.L., Kelly J.A., Bogart L.M., Benotsch E.G., McAuliffe T.A. Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000, 19:124-133.
18. Chabal C., Erjavec M.K., Jacobson L., Mariano A., Chaney E. Prescription opioid abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin. J. Pain 1997, 13:150-155.
19. Compton P. Should opioid abusers be discharged from opioid-analgesic therapy?. Pain Med. 2008, 9:383-390.
20. Conner K.R., Pinquart M., Duberstein P.R. Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). Addiction 2007, 103:524-534.
21. Conner K.R., Pinquart M., Holbrook A.P. Meta-analysis of depression and substance use and impairment among cocaine users. Drug Alcohol Depend. 2008, 98:13-23.
22. Conway K.P., Compton W., Stinson F.S., Grant B.F. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 2006, 67:247-257.
23. D'Acremont M., Van der Linden M. How is impulsivity related to depression in adolescence? Evidence from a french validation of the cognitive emotion regulation questionnaire. J. Adolesc. 2007, 30:271-282.
24. Dersh J., Mayer T.G., Gatchel R.J., Polatin P.B., Theodore B.R., Mayer E.A. Prescription opioid dependence is associated with poorer outcomes in disabling spinal disorders. Spine 2008, 33:2219-2227.
25. Diatchenko L., Slade G.D., Nackley A.G., Bhalang K., Sigurdsson A., Belfer I., Goldman D., Xu K., Shabalina S.A., Shagin D., Max M.B., Makarov S.S., Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet. 2005, 14:135-143.
26. Edlund M.J., Steffick D., Hudson T., Harris K.M., Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007, 129:355-362.
27. Edlund M.J., Sullivan M., Steffick D., Harris K.M., Wells K.B. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?. Pain Med. 2007, 8:647-656.
28. Edlund M.J. Chronic opioid therapy for chronic noncancer pain in the United States: long day's journey into night?. Gen. Hosp. Psychiatry 2011, 33:416-418.
29. Edwards R.R., Sarlani E., Wesselmann U., Fillingim R.B. Quantitative assessment of experimental pain perception: multiple domains of clinical relevance. Pain 2005, 114:315-319.
30. Edwards R.R. Individual differences in endogenous pain modulation as a risk factor for chronic pain. Neurology 2005, 65:437-443.
31. Edwards R.R., Bingham C.O., Bathon J., Haythornthwaite J.A. Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Rheum. 2006, 55:325-332.
32. Edwards R.R., Kronfli T., Haythornthwaite J.A., Smith M.T., McGuire L., Page G.G. Association of catastrophizing with interleukin-6 responses to acute pain. Pain 2008, 140:135-144.
33. Edwards R.R., Wasan A.D., Michna E., Greenbaum S., Ross E., Jamison R.N. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J. Pain 2011, 12:953-963.
34. Edwards R.R., Cahalan C., Mensing G., Smith M., Haythornthwaite J.A. Pain, catastrophizing, and depression in the rheumatic diseases. Nat. Rev. Rheumatol. 2011, 7:216-224.
35. Ferrari R., Capraro M., Visentin M. Risk factors in opioid treatment of chronic noncancer pain: a multidisciplinary assessment. Pain Management: Current Issues and Opinions 2012, 419-459. Intech, Rijeka. B. Gabor, C.E. Noe (Eds.).
36. Fillingim R.B., Lautenbacher S. The importance of quantitative sensory testing in the clinical setting. Pathophysiology of Pain Perception 2004, 215-227. Kluwer Academic, New York. S. Lautenbacher, R.B. Fillingim (Eds.).
37. Fillingim R.B., Ness T.J., Glover T.L., Campbell C.M., Price D.D., Staud R. Experimental pain models reveal no sex differences in pentazocine analgesia in humans. Anesthesiology 2004, 100:1263-1270.
38. Franques P., Auriacombe M., Piquemal E., Verger M., Brisseau-Gimenez S., Grabot D., Tignol J. Sensation seeking as a common factor in opioid dependent subjects and high risk sport practicing subjects. A cross sectional study. Drug Alcohol Depend. 2003, 69:121-126.
39. Gianoulakis C., de Waele J.P. Genetics of alcoholism: role of the endogenous opioid system. Metab. Brain Dis. 1994, 9:105-131.
40. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
41. Grattan A., Sullivan M.D., Saunders K.W., Campbell C.I., Von Korff M.R. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann. Fam. Med. 2012, 10:304-311.
42. Greenspan J.D., Slade G.D., Bair E., Dubner R., Fillingim R.B., Ohrbach R., Knott C., Mulkey F., Rothwell R., Maixner W. Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study. J. Pain 2011, 12:61-74.
43. Hasin D., Liu X., Nunes E. Effects of major depression on remission and relapse of substance dependence. Arch. Gen. Psychiatry 2002, 59:375-380.
44. Heckman B.D., Catz S.L., Heckman T.G., Miller J.G., Kalichman S.C. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care 2004, 16:219-230.
45. Holmbeck G.N. Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the child clinical and pediatric psychology literatures. J. Consult. Clin. Psychol. 1997, 65:599-610.
46. Ives T.J., Chelminski P.R., Hammett-Stabler C.A., Malone R.M., Perhac J.S., Potisek N.M., Shilliday B.B., DeWalt D.A., Pignone M.P. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv. Res. 2006, 6:46.
47. Jamison R.N., Link C.L., Marceau L.D. Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study. Pain Med. 2009, 10:1084-1094.
48. Jamison R.N., Ross E.L., Michna E., Chen L.Q., Holcomb C., Wasan A.D. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain 2010, 150:390-400.
49. Jamison R.N., Serraillier J., Michna E. Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Res. Treat. 2011, 12:1-12.
50. Keefe F.J., Kashikar-Zuck S., Robinson E., Salley A., Beaupre P., Caldwell D., Baucom D., Haythornthwaite J. Pain coping strategies that predict patients' and spouses' ratings of patients' self-efficacy. Pain 1997, 73:191-199.
51. Keefe F.J., Lefebvre J.C., Egert J.R., Affleck G., Sullivan M.J., Caldwell D.S. The relationship of gender to pain, pain behavior, and disability in osteoarthritis patients: the role of catastrophizing. Pain 2000, 87:325-334.
52. Keefe F.J., Lipkus I., Lefebvre J.C., Hurwitz H., Clipp E., Smith J., Porter L. The social context of gastrointestinal cancer pain: a preliminary study examining the relation of patient pain catastrophizing to patient perceptions of social support and caregiver stress and negative responses. Pain 2003, 103:151-156.
53. Keefe F.J., Affleck G., France C.R., Emery C.F., Waters S., Caldwell D.S., Stainbrook D., Hackshaw K.V., Fox L.C., Wilson K. Gender differences in pain, coping, and mood in individuals having osteoarthritic knee pain: a within-day analysis. Pain 2004, 110:571-577.
54. Khan R.S., Ahmed K., Blakeway E., Skapinakis P., Nihoyannopoulos L., Macleod K., Sevdalis N., Ashrafian H., Platt M., Darzi A., Athanasiou T. Catastrophizing: a predictive factor for postoperative pain. Am. J. Surg. 2011, 201:122-131.
55. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
56. McCracken L.M., Zayfert C., Gross R.T. The pain anxiety symptom scale: development and validation of a scale to measure fear of pain. Pain 1992, 50:67-73.
57. McCracken L.M., Dhingra L.A. Short version of the pain anxiety symptoms scale (PASS-20): preliminary development and validity. Pain Res. Manage. 2002, 7:45-50.
58. McKay J.R., Alterman A.I., Mulvaney F.D., Koppenhaver J.M. Predicting proximal factors in cocaine relapse and near miss episodes: clinical and theoretical implications. Drug Alcohol Depend. 1999, 56:67-78.
59. Michna E., Ross E.L., Hynes W.L., Nedeljkovic S.S., Soumekh S., Janfaza D., Palombi D., Jamison R.N. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J. Pain Symptom Manage. 2004, 28:250-258.
60. Millan M.J. Multiple opioid systems and pain. Pain 1986, 27:303-347.
61. Moeller F.G., Dougherty D.M., Barratt E.S., Oderinde V., Mathias C.W., Harper R.A., Swann A.C. Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol Depend. 2002, 68:105-111.
62. Morasco B.J., Dobscha S.K. Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen. Hosp. Psychiatry 2008, 30:93-99.
63. Morasco B.J., Turk D.C., Donovan D.M., Dobscha S.K. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend. 2013, 127:193-199.
64. Nicholas M.K. The pain self-efficacy questionnaire: taking pain into account. Eur. J. Pain 2007, 11:153-163.
65. Park J., Lavin R. Risk factors associated with opioid medication misuse in community-dwelling older adults with chronic pain. Clin. J. Pain 2010, 26:647-655.
66. Passik S.D., Lowery A. Psychological variables potentially implicated in opioid-related mortality as observed in clinical practice. Pain Med. 2011, 12:36-42.
67. Pertovaara A., Almeida A. Descending inhibitory systems. Handbook of Clinical Neurology 2006, 179-192. Elsevier, Amsterdam. F. Cervero, T.S. Jensen (Eds.).
68. Peters M.L., Vlaeyen J.W., Weber W.E. The joint contribution of physical pathology, pain-related fear and catastrophizing to chronic back pain disability. Pain 2005, 113:45-50.
69. Poole H., Bramwell R., Murphy P. Factor structure of the Beck Depression Inventory-II in patients with chronic pain. Clin. J. Pain 2006, 22:790-798.
70. Quartana P.J., Campbell C.M., Edwards R.R. Pain catastrophizing: a critical review. Expert Rev. Neurother. 2009, 9:745-758.
71. Roelofs J., McCracken L., Peters M.L., Crombez G., van Breukelen G., Vlaeyen J.W. Psychometric evaluation of the Pain Anxiety Symptoms Scale (PASS) in chronic pain patients. J. Behav. Med. 2004, 27:167-183.
72. Rosenthal T.L., Edwards N.B., Ackerman B.J., Knott D.H., Rosenthal R.H. Substance abuse patterns reveal contrasting personal traits. J. Subst. Abuse 1990, 2:255-263.
73. Schieffer B.M., Pham Q., Labus J., Baria A., Van Vort W., Davis P., Davis F., Naliboff B.D. Pain medication beliefs and medication misuse in chronic pain. J. Pain 2005, 6:620-629.
74. Sehgal N., Manchikanti L., Smith H.S. Prescription opioid abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin. J. Pain 2012, 15:67-92.
75. Shelby R.A., Somers T.J., Keefe F.J., Pells J.J., Dixon K.E., Blumenthal J.A. Domain specific self-efficacy mediates the impact of pain catastrophizing on pain and disability in overweight and obese osteoarthritis patients. J. Pain 2008, 9:912-919.
76. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl.) 2001, 158:343-359.
77. Sullivan M.J.L., Bishop S.R., Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol. Assess. 1995, 7:524-532.
78. Sullivan M.J.L., Thorn B., Haythornthwaite J.A., Keefe F., Martin M., Bradley L.A., Lefebvre J.C. Theoretical perspectives on the relation between catastrophizing and pain. Clin. J. Pain 2001, 17:52-64.
79. Sullivan M.J.L., Stanish W.D. Psychologically based occupational rehabilitation: the Pain-Disability Prevention Program. Clin. J. Pain 2003, 19:97-104.
80. Sullivan M.J.L., Tanzer M., Stanish W., Fallaha M., Keefe F.J., Simmonds M., Dunbar M. Psychological determinants of problematic outcomes following Total Knee Arthroplasty. Pain 2009, 143:123-129.
81. Sullivan M.D., Edlund M.J., Steffick D., Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005, 119:95-103.
82. Sullivan M.D., Edlund M.J., Fan M.Y., Devries A., Brennan Braden J., Martin B.C. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain 2010, 150:332-339.
83. Tan G., Jensen M.P., Thornby J.I., Shanti B.F. Validation of the brief pain inventory for nonmalignant pain. J. Pain 2004, 5:133-137.
84. Trafton J.A., Cucciare M.A., Lewis E., Oser M. Somatization is associated with non adherence to opioid prescriptions. J. Pain 2011, 12:573-580.
85. Turk D.C., Swanson K.S., Gatchel R.J. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin. J. Pain 2008, 24:497-508.
86. Vowles K.E., Gross R.T., Sorrell J.T. Predicting work status following interdisciplinary treatment for chronic pain. Eur. J. Pain 2004, 8:351-358.
87. Vyavaharkar M., Moneyham L., Tavakoli A., Phillips K.D., Murdaugh C., Jackson K., Meding G. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States. AIDS Patient Care 2007, 21:667-680.
88. Wasan A.D., Butler S.F., Budman S.H., Benoit C., Fernandez K., Jamison R.N. Psychiatric history and psychological adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin. J. Pain 2007, 23:307-315.
89. Wasan A.D., Butler S.F., Budman S.H., Fernandez K., Weiss R.D., Greenfield S.F., Jamison R.N. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?. Clin. J. Pain 2009, 25:193-198.
90. Webster B.S., Verma S.K., Gatchel R.J. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine 2007, 32:2127-2132.
91. Williams T.M., Daglish M.R., Lingford-Hughes A., Taylor L.G., Hammers A., Brooks D.J., Grasby P., Myles J.S., Nutt D.J. Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study. Br. J. Psychiatry 2007, 191:63-69.
92. Williams T.M., Davies S.J., Taylor L.G., Daglish M.R., Hammers A., Brooks D.J., Nutt D.J., Lingford-Hughes A. Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C] diprenorphine PET study. Eur. Neuropsychopharmacol. 2009, 19:740-748.
93. Wilsey B.L., Fishman S.M., Tsodikov A., Ogden C., Symreng I., Ernst A. Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med. 2008, 9:1107-1117.
94. Yarnitsky D., Pud D. Quantitative sensory testing. Clinical Neurophysiology. Revised and enlarged edition. EMG, Nerve Conduction and Evoked Potentials 2004, 309-336. Elsevier, Amsterdam. C. Binnie, R. Cooper, F. Mauguiere, J.W. Osselton, P. Prior, B. Tedman (Eds.).
95. Zubieta J.K., Gorelick D.A., Stauffer R., Ravert H.T., Dannals R.F., Frost J.J. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat. Med. 1996, 2:1225-1229.